Dong H, Chen S, Xing F
456 PLA Hospital, Jinan 250031.
Zhonghua Fu Chan Ke Za Zhi. 1999 Feb;34(2):94-6.
To evaluate the efficacy and safety of gonadotropin-releasing hormone agonist (GnRH-a) instead of hCG for triggering ovulation in high risk gonadotropin stimulating cycles of infertile polycystic ovary syndrome (PCOS) patients.
GnRH-a was given for triggering follicular final maturation and ovulation in 18 gonadotropin stimulating cycles of 14 PCOS patients with mean serum estradiol (E2) level of 8,379 +/- 2,958 pmol/L. Their outcomes and complications were analysed.
Ovulation achieved in 15 (83.3%) treated cycles, 4 (22.2%) became pregnant. Only 1 developed moderate ovarian hyperstimulation syndrome (OHSS) and another 1 had multiple pregnancy.
The use of GnRH-a instead of hCG in high risk gonadotropin stimulating cycles is able to successfully induce ovulation and pregnancy and decrease the incidence of severe OHSS and multiple gestation.
评估在多囊卵巢综合征(PCOS)不孕患者的高风险促性腺激素刺激周期中,使用促性腺激素释放激素激动剂(GnRH-a)代替人绒毛膜促性腺激素(hCG)触发排卵的有效性和安全性。
对14例多囊卵巢综合征患者的18个促性腺激素刺激周期给予GnRH-a以触发卵泡最终成熟和排卵,这些患者的血清雌二醇(E2)平均水平为8379±2958 pmol/L。分析其结局和并发症。
15个(83.3%)治疗周期实现排卵,4例(22.2%)怀孕。仅1例发生中度卵巢过度刺激综合征(OHSS),另1例为多胎妊娠。
在高风险促性腺激素刺激周期中使用GnRH-a代替hCG能够成功诱导排卵和妊娠,并降低严重OHSS和多胎妊娠的发生率。